Preparing Community Hospitals for CAR T’s Expansion

• by Kevin J. Land

• November 5, 2026

Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy

• by Florence Magrangeas, Mia Cherkaoui, Victor Bessonneau-Gaborit, Jennifer Derrien, Céline Chevalier, Catherine Guérin-Charbonnel, Benjamin Diamond, Mehmet Kemal Samur, Cyrille Hulin, Denis Caillot, Lionel Karlin, Bertrand Arnulf, Ola Landgren, Nikhil C. Munshi, Hervé Avet-Loiseau, Ludovic Martinet, Jill Corre, Aurore Perrot, Philippe Moreau, Cyrille Touzeau, Stéphane Minvielle, Eric Letouzé

• November 3, 2026

Esophageal cancer surgery: Bill’s story

Earnest pursuit of a second opinion after a cancer diagnosis is a great “patient-savvy” strategy for optimizing your treatment, recovery and survivorship options

• by

• October 27, 2026

• 7 min

From Evidence to Practice in Low-Risk Thyroid Cancer

• by Lia D. Delaney, Carolyn D. Seib

• October 30, 2026